作者
- Bhatt, D.L. (100)
- Chew, D.P. (9)
- Ellis, S.G. (16)
- Fonarow, G.C. (14)
- Hernandez, A.F. (12)
- Peterson, E.D. (18)
- Rajagopal, V. (10)
- Roe, M.T. (14)
- Steg, P.G. (10)
- Topol, E.J. (17)
|
總筆數:100
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Prevalence, predictors, and outcomes of patients with non-ST-segmentelevation myocardial infarction and insignificant coronary artery disease:Results from the Can Rapid risk stratification of Unstable angina patientsSuppress ADverse outcomes with Early implementation of the ACC/AHAGuidelines (CRUSADE) initiative |
Patel, M.R.;Chen, A.Y.;Peterson, E.D.;Newby, L.K.;Pollack, C.V.;Brindis, R.G.;Gibson, C.M.;Kleiman, N.S.;Saucedo, J.F.;Bhatt, D.L.;Gibler, W.B.;Ohman, E.M.;Harrington, R.A.;Roe, M.T.; |
American Heart Journal |
2006-10-01 |
查看 |
| Response to Letter to the Editor |
Chen, M.S.;Bhatt, D.L.; |
American Heart Journal |
2006-11-01 |
查看 |
| Bhatt response to the letter to the editor by Michaels |
Chen, M.S.;Bhatt, D.L.; |
American Heart Journal |
2007-03-01 |
查看 |
| Bhatt response to the letter to the editor by Michaels |
Chen, M.S.;Bhatt, D.L.; |
American Heart Journal |
2007-03-01 |
查看 |
| Bhatt response to the letter to the editor by Michaels |
Chen, M.S.;Bhatt, D.L.; |
American Heart Journal |
2007-03-01 |
查看 |
| Acute myocardial infarction and drug-eluting stents: A green light fortheir use or time for measured restraint? |
Bavry, A.A.;Bhatt, D.L.; |
American Heart Journal |
2007-05-01 |
查看 |
| Peroxisome proliferator-activated receptor @c agonists for thePrevention of Adverse events following percutaneous coronaryRevascularization-results of the PPAR Study |
Bhatt, D.L.;Chew, D.P.;Grines, C.;Mukherjee, D.;Leesar, M.;Gilchrist, I.C.;Corbelli, J.C.;Blankenship, J.C.;Eres, A.;Steinhubl, S.;Tan, W.A.;Resar, J.R.;AlMahameed, A.;Abdel-Latif, A.;Tang, H.W.;Brennan, D.;McErlean, E.;Hazen, S.L.;Topol, E.J.; |
American Heart Journal |
2007-07-01 |
查看 |
| Peroxisome proliferator-activated receptor @c agonists for thePrevention of Adverse events following percutaneous coronaryRevascularization-results of the PPAR Study |
Bhatt, D.L.;Chew, D.P.;Grines, C.;Mukherjee, D.;Leesar, M.;Gilchrist, I.C.;Corbelli, J.C.;Blankenship, J.C.;Eres, A.;Steinhubl, S.;Tan, W.A.;Resar, J.R.;AlMahameed, A.;Abdel-Latif, A.;Tang, H.W.;Brennan, D.;McErlean, E.;Hazen, S.L.;Topol, E.J.; |
American Heart Journal |
2007-07-01 |
查看 |
| Designing the ideal risk model for acute coronary syndromes-is simplebetter than complex? |
Bavry, A.A.;Bhatt, D.L.; |
American Heart Journal |
2007-08-01 |
查看 |
| Designing the ideal risk model for acute coronary syndromes-is simplebetter than complex? |
Bavry, A.A.;Bhatt, D.L.; |
American Heart Journal |
2007-08-01 |
查看 |
| Culprit-only or multivessel revascularization in patients with acutecoronary syndromes |
Brener, S.J.;Milford-Beland, S.;Roe, M.T.;Bhatt, D.L.;Weintraub, W.S.;Brindis, R.G.; |
American Heart Journal |
2008-01-01 |
查看 |
| Culprit-only or multivessel revascularization in patients with acutecoronary syndromes |
Brener, S.J.;Milford-Beland, S.;Roe, M.T.;Bhatt, D.L.;Weintraub, W.S.;Brindis, R.G.; |
American Heart Journal |
2008-01-01 |
查看 |
| Renal function, atherothrombosis extent, and outcomes in high-riskpatients |
on behalf of the REACH Registry Investigators;Dumaine, R.L.;Montalescot, G.;Steg, Ph.G.;Ohman, E.M.;Eagle, K.;Bhatt, D.L.; |
American Heart Journal |
2009-07-01 |
查看 |
| Drug-eluting versus bare-metal stents for treating saphenous vein grafts |
Shishehbor, M.H.;Hawi, R.;Singh, I.M.;Tuzcu, E.M.;Bhatt, D.L.;Ellis, S.G.;Kapadia, S.R.; |
American Heart Journal |
2009-10-01 |
查看 |
| Ethnic differences in the prevalence and treatment of cardiovascularrisk factors in US outpatients with peripheral arterial disease: Insightsfrom the Reduction of Atherothrombosis for Continued Health (REACH) Registry |
on behalf of the REACH Registry Investigators;Meadows, T.A.;Bhatt, D.L.;Hirsch, A.T.;Creager, M.A.;Califf, R.M.;Ohman, E.M.;Cannon, C.P.;Eagle, K.A.;Alberts, M.J.;Goto, S.;Smith, S.C.;Wilson, P.W.F.;Watson, K.E.;Steg, P.G.; |
American Heart Journal |
2009-12-01 |
查看 |
| Bridging the gap between clinical trials of antiplatelet therapies andapplications among elderly patients |
Dauerman, H.L.;Bhatt, D.L.;Gretler, D.D.;French, P.A.;Smyth, S.S.;Becker, R.C.; |
American Heart Journal |
2010-04-01 |
查看 |
| Rationale and design of the randomized, double-blind trial testingINtraveNous and Oral administration of elinogrel, a selective andreversible P2Y"1"2-receptor inhibitor, versus clopidogrel to eVAluateTolerability and Efficacy in nonurgent Percutaneous Coronary Interventionspatients (INNOVATE-PCI) |
Leonardi, S.;Rao, S.V.;Harrington, R.A.;Bhatt, D.L.;Gibson, C.M.;Roe, M.T.;Kochman, J.;Huber, K.;Zeymer, U.;Madan, M.;Gretler, D.D.;McClure, M.W.;Paynter, G.E.;Thompson, V.;Welsh, R.C.; |
American Heart Journal |
2010-07-01 |
查看 |
| Use of intensive lipid-lowering therapy in patients hospitalized withacute coronary syndrome: An analysis of 65,396 hospitalizations from 344hospitals participating in Get With The Guidelines (GWTG) |
Javed, U.;Deedwania, P.C.;Bhatt, D.L.;Cannon, C.P.;Dai, D.;Hernandez, A.F.;Peterson, E.D.;Fonarow, G.C.; |
American Heart Journal |
2010-12-01 |
查看 |
| Use of intensive lipid-lowering therapy in patients hospitalized withacute coronary syndrome: An analysis of 65,396 hospitalizations from 344hospitals participating in Get With The Guidelines (GWTG) |
Javed, U.;Deedwania, P.C.;Bhatt, D.L.;Cannon, C.P.;Dai, D.;Hernandez, A.F.;Peterson, E.D.;Fonarow, G.C.; |
American Heart Journal |
2011-02-01 |
查看 |
| Clinical outcomes after percutaneous revascularization versus medicalmanagement in patients with significant renal artery stenosis: Ameta-analysis of randomized controlled trials |
Kumbhani, D.J.;Bavry, A.A.;Harvey, J.E.;de Souza, R.;Scarpioni, R.;Bhatt, D.L.;Kapadia, S.R.; |
American Heart Journal |
2011-03-01 |
查看 |
| Bleeding, mortality, and antiplatelet therapy: Results from theClopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management, and Avoidance (CHARISMA) trial |
Berger, J.S.;Bhatt, D.L.;Steg, P.G.;Steinhubl, S.R.;Montalescot, G.;Shao, M.;Hacke, W.;Fox, K.A.;Berger, P.B.;Topol, E.J.;Lincoff, A.M.; |
American Heart Journal |
2011-07-01 |
查看 |
| Quality of acute myocardial infarction care and outcomes in 33,997patients aged 80 years or older: Findings from Get With TheGuidelines-Coronary Artery Disease (GWTG-CAD) |
Medina, H.M.;Cannon, C.P.;Zhao, X.;Hernandez, A.F.;Bhatt, D.L.;Peterson, E.D.;Liang, L.;Fonarow, G.C.; |
American Heart Journal |
2011-08-01 |
查看 |
| Improvement in use of anticoagulation therapy in patients with ischemicstroke: Results from Get With The Guidelines-Stroke |
Lewis, W.R.;Fonarow, G.C.;Grau-Sepulveda, M.V.;Smith, E.E.;Bhatt, D.L.;Hernandez, A.F.;Olson, D.;Peterson, E.D.;Schwamm, L.H.; |
American Heart Journal |
2011-10-01 |
查看 |
| The design and rationale of the Saxagliptin Assessment of VascularOutcomes Recorded in patients with diabetes mellitus-Thrombolysis inMyocardial Infarction (SAVOR-TIMI) 53 Study |
Scirica, B.M.;Bhatt, D.L.;Braunwald, E.;Steg, Ph.G.;Davidson, J.;Hirshberg, B.;Ohman, P.;Price, D.L.;Chen, R.;Udell, J.;Raz, I.; |
American Heart Journal |
2011-11-01 |
查看 |
| The design and rationale of the Saxagliptin Assessment of VascularOutcomes Recorded in patients with diabetes mellitus-Thrombolysis inMyocardial Infarction (SAVOR-TIMI) 53 Study |
Scirica, B.M.;Bhatt, D.L.;Braunwald, E.;Steg, Ph.G.;Davidson, J.;Hirshberg, B.;Ohman, P.;Price, D.L.;Chen, R.;Udell, J.;Raz, I.; |
American Heart Journal |
2011-11-01 |
查看 |
| Regional differences in clinical profile, quality of care, and outcomesamong Hispanic patients hospitalized with acute myocardial infarction inthe Get with Guidelines-Coronary Artery Disease (GWTG-CAD) Registry |
Krim, S.R.;Vivo, R.P.;Krim, N.R.;Cox, M.;Hernandez, A.F.;Peterson, E.D.;Fonarow, G.C.;Pina, I.L.;Schwamm, L.H.;Bhatt, D.L.; |
American Heart Journal |
2011-12-01 |
查看 |
| Reply to the letter by Chatterjee et al ''Bleeding, mortality, andantiplatelet therapy: Results from the Clopidogrel for HighAtherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance(CHARISMA) trial'' |
Berger, J.S.;Bhatt, D.L.; |
American Heart Journal |
2012-01-01 |
查看 |
| Reduced immediate ischemic events with cangrelor in PCI: A pooledanalysis of the CHAMPION trials using the universal definition ofmyocardial infarction |
White, H.D.;Chew, D.P.;Dauerman, H.L.;Mahaffey, K.W.;Gibson, C.M.;Stone, G.W.;Gruberg, L.;Harrington, R.A.;Bhatt, D.L.; |
American Heart Journal |
2012-02-01 |
查看 |
| Sex differences in in-hospital mortality in acute decompensated heartfailure with reduced and preserved ejection fraction |
Hsich, E.M.;Grau-Sepulveda, M.V.;Hernandez, A.F.;Peterson, E.D.;Schwamm, L.H.;Bhatt, D.L.;Fonarow, G.C.; |
American Heart Journal |
2012-03-01 |
查看 |
| Rationale and design of the Cangrelor versus standard therapy toacHieve optimal Management of Platelet InhibitiON PHOENIX trial |
Leonardi, S.;Mahaffey, K.W.;White, H.D.;Gibson, C.M.;Stone, G.W.;Steg, G.W.;Hamm, C.W.;Price, M.J.;Todd, M.;Dietrich, M.;Gallup, D.;Liu, T.;Skerjanec, S.;Harrington, R.A.;Bhatt, D.L.; |
American Heart Journal |
2012-05-01 |
查看 |
| Optimized Duration of Clopidogrel Therapy Following Treatment with theEndeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice(OPTIMIZE) Trial: Rationale and design of a large-scale, randomized,multicenter study |
Feres, F.;Costa, R.A.;Bhatt, D.L.;Leon, M.B.;Botelho, R.V.;King, S.B.;de Paula, J.E.T.;Mangione, J.A.;Salvadori, D.;Gusmao, M.O.;Castello, H.;Nicolela, E.;Perin, M.A.;Devito, F.S.;Marin-Neto, J.A.;Abizaid, A.; |
American Heart Journal |
2012-12-01 |
查看 |
| Admission heart rate and in-hospital outcomes in patients hospitalizedfor heart failure in sinus rhythm and in atrial fibrillation |
Bui, A.L.;Grau-Sepulveda, M.V.;Hernandez, A.F.;Peterson, E.D.;Yancy, C.W.;Bhatt, D.L.;Fonarow, G.C.; |
American Heart Journal |
2013-04-01 |
查看 |
| Prognostic significance of presenting blood pressure in non-ST-segmentelevation acute coronary syndrome in relation to prior history ofhypertension |
Lee, D.;Goodman, S.G.;Fox, K.A.A.;DeYoung, J.P.;Lai, C.C.;Bhatt, D.L.;Huynh, T.;Yan, R.T.;Gallo, R.;Steg, Ph.G.;Yan, A.T.; |
American Heart Journal |
2013-10-01 |
查看 |
| Relationship between sex, ejection fraction, and B-type natriureticpeptide levels in patients hospitalized with heart failure and associationswith inhospital outcomes: Findings from the Get With The Guideline-HeartFailure Registry |
Hsich, E.M.;Grau-Sepulveda, M.V.;Hernandez, A.F.;Eapen, Z.J.;Xian, Y.;Schwamm, L.H.;Bhatt, D.L.;Fonarow, G.C.; |
American Heart Journal |
2013-12-01 |
查看 |
| Hospital patterns of medical management strategy use for patients withnon-ST-elevation myocardial infarction and 3-vessel or left main coronaryartery disease |
Harskamp, R.E.;Wang, T.Y.;Bhatt, D.L.;Wiviott, S.D.;Amsterdam, E.A.;Li, S.;Thomas, L.;de Winter, R.J.;Roe, M.T.; |
American Heart Journal |
2014-03-01 |
查看 |
| Proceedings from Duke Resistant Hypertension Think Tank |
Vemulapalli, S.;Ard, J.;Bakris, G.L.;Bhatt, D.L.;Brown, A.S.;Cushman, W.C.;Ferdinand, K.C.;Flack, J.M.;Fleg, J.L.;Katzen, B.T.;Kostis, J.B.;Oparil, S.;Patel, C.B.;Pepine, C.J.;Pina, I.L.;Rocha-Singh, K.J.;Townsend, R.R.;Peterson, E.D.;Califf, R.M.;Patel, M.R.; |
American Heart Journal |
2014-06-01 |
查看 |
| Implications of prior myocardial infarction for patients presentingwith an acute myocardial infarction |
Shen, L.;Shah, B.R.;Nam, A.;Holmes, D.;Alexander, K.P.;Bhatt, D.L.;Ho, P.M.;Peterson, E.D.;He, B.;Roe, M.T.; |
American Heart Journal |
2014-06-01 |
查看 |
| Proceedings from Duke Resistant Hypertension Think Tank |
Vemulapalli, S.;Ard, J.;Bakris, G.L.;Bhatt, D.L.;Brown, A.S.;Cushman, W.C.;Ferdinand, K.C.;Flack, J.M.;Fleg, J.L.;Katzen, B.T.;Kostis, J.B.;Oparil, S.;Patel, C.B.;Pepine, C.J.;Pina, I.L.;Rocha-Singh, K.J.;Townsend, R.R.;Peterson, E.D.;Califf, R.M.;Patel, M.R.; |
American Heart Journal |
2014-06-01 |
查看 |
| Implications of prior myocardial infarction for patients presentingwith an acute myocardial infarction |
Shen, L.;Shah, B.R.;Nam, A.;Holmes, D.;Alexander, K.P.;Bhatt, D.L.;Ho, P.M.;Peterson, E.D.;He, B.;Roe, M.T.; |
American Heart Journal |
2014-06-01 |
查看 |
| Effect of alirocumab, a monoclonal antibody to PCSK9, on long-termcardiovascular outcomes following acute coronary syndromes: Rationale anddesign of the ODYSSEY Outcomes trial |
Schwartz, G.G.;Bessac, L.;Berdan, L.G.;Bhatt, D.L.;Bittner, V.;Diaz, R.;Goodman, S.G.;Hanotin, C.;Harrington, R.A.;Jukema, J.W.;Mahaffey, K.W.;Moryusef, A.;Pordy, R.;Roe, M.T.;Rorick, T.;Sasiela, W.J.;Shirodaria, C.;Szarek, M.;Tamby, J.F.;Tricoci, P.;White, H.;Zeiher, A.;Steg, P.G.; |
American Heart Journal |
2014-11-01 |
查看 |
| Outcomes in patients with heart failure with preserved, borderline, andreduced ejection fraction in the Medicare population |
Cheng, R.K.;Cox, M.;Neely, M.L.;Heidenreich, P.A.;Bhatt, D.L.;Eapen, Z.J.;Hernandez, A.F.;Butler, J.;Yancy, C.W.;Fonarow, G.C.; |
American Heart Journal |
2014-11-01 |
查看 |
| Outcomes in patients with heart failure with preserved, borderline, andreduced ejection fraction in the Medicare population |
Cheng, R.K.;Cox, M.;Neely, M.L.;Heidenreich, P.A.;Bhatt, D.L.;Eapen, Z.J.;Hernandez, A.F.;Butler, J.;Yancy, C.W.;Fonarow, G.C.; |
American Heart Journal |
2014-11-01 |
查看 |
| Effect of alirocumab, a monoclonal antibody to PCSK9, on long-termcardiovascular outcomes following acute coronary syndromes: Rationale anddesign of the ODYSSEY Outcomes trial |
Schwartz, G.G.;Bessac, L.;Berdan, L.G.;Bhatt, D.L.;Bittner, V.;Diaz, R.;Goodman, S.G.;Hanotin, C.;Harrington, R.A.;Jukema, J.W.;Mahaffey, K.W.;Moryusef, A.;Pordy, R.;Roe, M.T.;Rorick, T.;Sasiela, W.J.;Shirodaria, C.;Szarek, M.;Tamby, J.F.;Tricoci, P.;White, H.;Zeiher, A.;Steg, P.G.; |
American Heart Journal |
2014-11-01 |
查看 |
| Targeted versus standard feedback: Results from a Randomized QualityImprovement Trial |
Lytle, B.L.;Li, S.;Lofthus, D.M.;Thomas, L.;Poteat, J.L.;Bhatt, D.L.;Cannon, C.P.;Fonarow, G.C.;Peterson, E.D.;Wang, T.Y.;Alexander, K.P.; |
American Heart Journal |
2015-01-01 |
查看 |
| Targeted versus standard feedback: Results from a Randomized QualityImprovement Trial |
Lytle, B.L.;Li, S.;Lofthus, D.M.;Thomas, L.;Poteat, J.L.;Bhatt, D.L.;Cannon, C.P.;Fonarow, G.C.;Peterson, E.D.;Wang, T.Y.;Alexander, K.P.; |
American Heart Journal |
2015-01-01 |
查看 |
| Early P2Y"1"2 inhibition in ST-segment elevation myocardial infarction:Bridging the gap |
Alexopoulos, D.;Bhatt, D.L.;Hamm, C.W.;Steg, P.G.;Stone, G.W.; |
American Heart Journal |
2015-07-01 |
查看 |
| Concomitant proton-pump inhibitor use, platelet activity, and clinicaloutcomes in patients with acute coronary syndromes treated with prasugrelversus clopidogrel and managed without revascularization: Insights from theTargeted Platelet Inhibition to Clarify the Optimal Strategy to MedicallyManage Acute Coronary Syndromes trial |
TRILOGY ACS investigators;Nicolau, J.C.;Bhatt, D.L.;Roe, M.T.;Lokhnygina, Y.;Neely, B.;Corbalan, R.;Leiva-Pons, J.L.;Martinez, F.;Goodman, S.G.;Winters, K.J.;Verheugt, F.W.A.;Armstrong, P.W.;White, H.D.;Fox, K.A.A.;Prabhakaran, D.;Ohman, E.M.; |
American Heart Journal |
2015-10-01 |
查看 |
| Multivessel vs culprit-only percutaneous coronary intervention amongpatients 65 years or older with acute myocardial infarction |
Wang, T.Y.;McCoy, L.A.;Bhatt, D.L.;Rao, S.V.;Roe, M.T.;Resnic, F.S.;Cavender, M.A.;Messenger, J.C.;Peterson, E.D.; |
American Heart Journal |
2016-02-01 |
查看 |
| Statin use, intensity, and 3-year clinical outcomes among olderpatients with coronary artery disease |
O'Brien, E.C.;Wu, J.;Schulte, P.J.;Christian, A.;Laskey, W.;Bhatt, D.L.;Peterson, E.D.;Hernandez, A.F.;Fonarow, G.C.; |
American Heart Journal |
2016-03-01 |
查看 |
| Statin use, intensity, and 3-year clinical outcomes among olderpatients with coronary artery disease |
O'Brien, E.C.;Wu, J.;Schulte, P.J.;Christian, A.;Laskey, W.;Bhatt, D.L.;Peterson, E.D.;Hernandez, A.F.;Fonarow, G.C.; |
American Heart Journal |
2016-03-01 |
查看 |
|
|
|
